IL17RC
Interleukin-17 receptor C
Also known as: I17RC_HUMAN, IL17-RL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NAC3
- Gene
- IL17RC
- Ensembl
- ENSG00000163702
- Chromosome
- 3
- Canonical length
- 791 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a single-pass type I membrane protein that shares similarity with the interleukin-17 receptor (IL-17RA). Unlike IL-17RA, which is predominantly expressed in hemopoietic cells, and binds with high affinity to only IL-17A, this protein is expressed in nonhemopoietic tissues, and binds both IL-17A and IL-17F with similar affinities. The proinflammatory cytokines, IL-17A and IL-17F, have been implicated in the progression of inflammatory and autoimmune diseases. Multiple alternatively spliced transcript variants encoding different isoforms have been detected for this gene, and it has been proposed that soluble, secreted proteins lacking transmembrane and intracellular domains may function as extracellular antagonists to cytokine signaling. [provided by RefSeq, Feb 2011]
Canonical amino-acid sequenceUniProt
791 residues, UniProt reviewed canonical sequence.
>Q8NAC3|IL17RC
1 MPVPWFLLSL ALGRSPVVLS LERLVGPQDA THCSPVSLEP WGDEERLRVQ FLAQQSLSLA
61 PVTAATARTA LSGLSGADGR REERGRGKSW VCLSLGGSGN TEPQKKGLSC RLWDSDILCL
121 PGDIVPAPGP VLAPTHLQTE LVLRCQKETD CDLCLRVAVH LAVHGHWEEP EDEEKFGGAA
181 DSGVEEPRNA SLQAQVVLSF QAYPTARCVL LEVQVPAALV QFGQSVGSVV YDCFEAALGS
241 EVRIWSYTQP RYEKELNHTQ QLPDCRGLEV WNSIPSCWAL PWLNVSADGD NVHLVLNVSE
301 EQHFGLSLYW NQVQGPPKPR WHKNLTGPQI ITLNHTDLVP CLCIQVWPLE PDSVRTNICP
361 FREDPRAHQN LWQAARLQLL TLQSWLLDAP CSLPAEAALC WRAPGGDPCQ PLVPPLSWEN
421 VTVDKVLEFP LLKGHPNLCV QVNSSEKLQL QECLWADSLG PLKDDVLLLE TRGPQDNRSL
481 CALEPSGCTS LPSKASTRAA RLGEYLLQDL QSGQCLQLWD DDLGALWACP MDKYIHKRWA
541 LVWLACLLFA AALSLILLLK KDHAKGWLRL LKQDVRSGAA ARGRAALLLY SADDSGFERL
601 VGALASALCQ LPLRVAVDLW SRRELSAQGP VAWFHAQRRQ TLQEGGVVVL LFSPGAVALC
661 SEWLQDGVSG PGAHGPHDAF RASLSCVLPD FLQGRAPGSY VGACFDRLLH PDAVPALFRT
721 VPVFTLPSQL PDFLGALQQP RAPRSGRLQE RAEQVSRALQ PALDSYFHPP GTPAPGRGVG
781 PGAGPGAGDG TLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL17RC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 64 nTPM
Expression across tissuesHPA
Tissue
- liver: 64 nTPM
- adrenal gland: 32 nTPM
- skin: 31 nTPM
- prostate: 30 nTPM
- pituitary gland: 28 nTPM
- salivary gland: 24 nTPM
Single-cell type
- astrocytes: 29 nCPM
- proximal tubule cells: 24 nCPM
- ependymal cells: 16 nCPM
- podocytes: 16 nCPM
- bergmann glia: 15 nCPM
- oligodendrocyte progenitor cells: 14 nCPM
Immune cell
- myeloid DC: 3 nTPM
- classical monocyte: 2.2 nTPM
- non-classical monocyte: 2.1 nTPM
- naive B-cell: 1.5 nTPM
- total PBMC: 1.5 nTPM
- naive CD4 T-cell: 0.9 nTPM
Brain region
- spinal cord: 17 nTPM
- cerebral cortex: 16 nTPM
- thalamus: 16 nTPM
- medulla oblongata: 15 nTPM
- midbrain: 15 nTPM
- hypothalamus: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about IL17RC.
Disease | AllUniProt
Conditions IL17RC is implicated in, by any mechanism.
- Candidiasis, familial, 9 (CANDF9) MIM:616445
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 903 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Candidiasis, familial, 9
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.87
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.09
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- defense response to fungus
- granulocyte chemotaxis
- inflammatory response
- interleukin-17A-mediated signaling pathway
- positive regulation of cytokine production involved in inflammatory response
- positive regulation of interleukin-6 production
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL17RC in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL17RC as an antibody target. Whether an autoantibody or antibody against IL17RC could matter depends on whether native IL17RC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL17RC is annotated at the cell surface, where native IL17RC is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- The proinflammatory cytokines, IL-17A and IL-17F, have been implicated in the progression of inflammatory and autoimmune diseases.
Loading the interactive Seroatlas protein explorer...